Improved quality control of [177Lu]Lu-PSMA I&T

被引：0
|
作者：
Martin Kraihammer
Piotr Garnuszek
Andreas Bauman
Michael Maurin
Manuel Alejandre Lafont
Roland Haubner
Elisabeth von Guggenberg
Michael Gabriel
Clemens Decristoforo
机构：
[1] Medical University Innsbruck,Department of Nuclear Medicine
[2] Kepler University Hospital,Department of Nuclear Medicine and Endocrinology
[3] National Centre for Nuclear Research,Radioisotope Centre POLATOM
[4] University Hospital Basel,Division of Radiopharmaceutical Chemistry
来源：
EJNMMI Radiopharmacy and Chemistry | / 8卷
关键词：
PSMA; [; Lu]Lu-PSMA I&T; Zadavotide guraxetan; Radionuclide therapy; Quality control; HPLC; TLC; Validation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Estimation of relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS
    Rumiantcev, Mikhail
    Li, Wei Bo
    Lindner, Simon
    Liubchenko, Grigory
    Resch, Sandra
    Bartenstein, Peter
    Ziegler, Sibylle I.
    Boening, Guido
    Delker, Astrid
    EJNMMI PHYSICS, 2023, 10 (01)
  • [22] Radionuclide therapy with 177Lu PSMA for prostate cancer
    da Rocha, Euclides Timoteo
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1527 - 1527
  • [23] Lu-177 PSMA I&T Therapy for Prostate Cancer; Treatment Response, Treatment Toxicity, and Survival Results
    Acar, Emine
    Sonmezer, Burak
    Derebek, Erkan
    Bekis, Recep
    Ozdogan, Ozhan
    Kaya, Gamze Capa
    JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2019, 3 (03): : 158 - 164
  • [24] Towards Routine Clinical Use of Dosimetry in [177Lu]Lu-PSMA Prostate Cancer Radionuclide Therapy: Current Efforts and Future Perspectives
    Alsadi, Rahaf
    Djekidel, Mehdi
    Bouhali, Othmane
    Doherty, Jim O'
    FRONTIERS IN PHYSICS, 2022, 10
  • [25] Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand
    Chatachot, Kotchakorn
    Shiratori, Shuichi
    Chaiwatanarat, Tawatchai
    Khamwan, Kitiwat
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (11) : 1193 - 1202
  • [26] Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand
    Kotchakorn Chatachot
    Shuichi Shiratori
    Tawatchai Chaiwatanarat
    Kitiwat Khamwan
    Annals of Nuclear Medicine, 2021, 35 : 1193 - 1202
  • [27] The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival
    Acar, Emine
    Ozdogan, Ozhan
    Aksu, Aysegul
    Derebek, Erkan
    Bekis, Recep
    Kaya, Gamze Capa
    ANNALS OF NUCLEAR MEDICINE, 2019, 33 (09) : 681 - 688
  • [28] Automated radiosynthesis of [177Lu] Lu-PSMA-617 on the iPHASE MultiSyn module
    Wichmann, Christian
    Ackermann, Uwe
    Poniger, Stan
    Young, Kenneth
    Chan, James
    Hofman, Michael
    Sachinidis, John
    Scott, Andrew
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S329 - S329
  • [29] AUTOMATED RADIOSYNTHESIS OF [177LU]LU-PSMA-617 ON THE IPHASE MULTISYN MODULE
    Wichmann, C.
    Ackermann, U.
    Poniger, Stan
    Young, K.
    Chan, G.
    Hofman, M.
    Lee, S. T.
    Sachinidis, J.
    Scott, A.
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 31 - 32
  • [30] The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival
    Emine Acar
    Özhan Özdoğan
    Ayşegül Aksu
    Erkan Derebek
    Recep Bekiş
    Gamze Çapa Kaya
    Annals of Nuclear Medicine, 2019, 33 : 681 - 688
12345